Home › Idiopathic Hypersomnia › Florida › Orlando
Idiopathic Hypersomnia clinical trials in Orlando, FL
6 studies for Idiopathic Hypersomnia are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
RecruitingPhase 2/3
- Takeda Site 18, Winter Park · 5 mi away
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
RecruitingPhase 3
- Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC), Winter Park · 5 mi away
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Winter Park · 5 mi away
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
RecruitingPhase 2
- Takeda Site 14, Winter Park · 5 mi away
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Orlando, FL, Orlando
- Winter Park, Florida, Winter Park · 5 mi away
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Orlando, Florida, Orlando
- Winter Park, FL, Winter Park · 5 mi away
Idiopathic Hypersomnia trials in other cities
- Cincinnati, OH7 studies
- Charlotte, NC6 studies
- San Antonio, TX5 studies
- Columbia, SC5 studies
- Atlanta, GA5 studies
- Miami, FL5 studies
- Austin, TX5 studies
- Brandon, FL4 studies
- Colorado Springs, CO4 studies
- Philadelphia, PA4 studies
- Columbus, OH4 studies
- Sterling Heights, MI4 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity29 studies
- Metastatic Cancer29 studies
- Alzheimer's Disease25 studies
- Cancer (all types)25 studies
- Overweight25 studies
- Type 2 Diabetes24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Major Depressive Disorder19 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.